查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1908243

下一代定序市场规模、份额和趋势分析报告：按技术、产品、应用、工作流程、最终用途、地区和细分市场预测（2026-2033 年）

Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology, By Product, By Application, By Workflow, By End Use, By Region And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

下一代定序市场概览

全球次世代定序市场预计到 2025 年价值 112.6 亿美元，预计到 2033 年将达到 422.5 亿美元。

预计从 2026 年到 2033 年，该产业将以 18.00% 的复合年增长率成长。这一增长是由对先进基因组研究的需求不断增长、下一代测序 (NGS) 在临床诊断中应用范围不断扩大以及测序平台技术的持续进步所推动的。

目录

第一章调查方法和范围

第二章执行摘要

第三章 市场变数与趋势

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关及辅助市场展望
  • 市场趋势与展望
  • 市场动态
  • 市场分析工具
    • SWOT分析（按因素划分：政治/法律法规、经济、技术）
    • 波特五力分析

第四章 技术业务分析

  • 下一代定序资料分析市场：技术变革分析
  • 标靶定序和重定序
    • 标靶定序和重测序市场估算和预测（2021-2033）
    • 基于DNA的标靶定序与重定序
    • 基于RNA的标靶定序和重测序
  • 全基因组定序
  • 全外EXOME定序

第五章 产品业务分析

  • 下一代定序资料分析市场：产品变异分析
  • 平台
    • 平台市场估算与预测（2021-2033）
    • 顺序
    • 数据分析
  • 消耗品
    • 样品製备
    • 目标富集
    • 其他的

第六章：应用业务分析

  • 下一代定序资料分析市场：应用变异分析
  • 肿瘤学
    • 诊断和筛检
    • 研究调查
  • 临床研究
    • 感染疾病
    • 特发性疾病
    • 遗传性疾病
    • 非传染性疾病/其他疾病
  • 生殖医学
    • NIPT
    • PGT
    • 新生儿基因筛检
    • 单基因分析市场
  • HLA型检测/免疫系统监测
    • 总体基因体学、流行病学和药物研发
    • 农业基因组学与法医学
    • 消费者基因体学

第七章 工作流程业务分析

  • 下一代定序资料分析市场：工作流程变异分析
  • 前序
    • 预测序市场估计与预测（2021-2033）
    • 核酸萃取
    • 样品製备
  • 顺序
  • 数据分析

第八章 最终用户业务分析

  • 下一代定序市场：依最终用途分類的差异分析
  • 学术研究
  • 临床研究
  • 医院和诊所
  • 製药和生物技术公司
  • 其他用户

第九章：区域商业分析

  • 2025 年及 2033 年各地区次世代定序市场份额
  • 北美洲
    • 2021-2033年北美次世代定序市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2021-2033年欧洲次世代定序市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区次世代定序市场，2021-2033年
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2021-2033年拉丁美洲次世代定序市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2021-2033年中东及非洲次世代定序市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2025年商业市场分析
  • 公司简介/列表
    • Illumina
    • F. Hoffman-La Roche Ltd.
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Oxford Nanopore Technologies
    • Revvity, Inc.
    • PacBio
    • Merk KGaA
    • BGI
Product Code: 978-1-68038-428-4

Next Generation Sequencing Market Summary

The global next-generation sequencing market size was estimated at USD 11.26 billion in 2025 and is projected to reach USD 42.25 billion by 2033, growing at a CAGR of 18.00% from 2026 to 2033. This growth is driven by the increasing demand for advanced genomic research, rising applications of NGS in clinical diagnostics, and ongoing technological advancements in sequencing platforms.

Global Next Generation Sequencing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global next-generation sequencing market report based on the technology, product, workflow, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • WGS
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing
    • DNA-based
    • RNA-based
  • Others
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Platform
    • Sequencing
    • Data Analysis
  • Consumables
    • Sample Preparation
    • Target Enrichment
    • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
    • Diagnostics and Screening
    • Oncology Screening
    • Sporadic Cancer
    • Inherited Cancer
    • Companion Diagnostics
    • Other Diagnostics
    • Research Studies
  • Clinical Investigation
    • Infectious Diseases
    • Inherited Diseases
    • Idiopathic Diseases
    • Non-Communicable/Other Diseases
  • Reproductive Health
    • NIPT
    • Aneuploidy
    • Microdeletions
    • PGT
    • Newborn Genetic Screening
    • Single Gene Analysis
  • HLA Typing/Immune System Monitoring
  • Metagenomics, Epidemiology & Drug Development
  • Agrigenomics & Forensics
  • Consumer Genomics
  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Pre-Sequencing
    • Nucleic Acid Extraction
    • Library Preparation
  • Sequencing
  • NGS Data Analysis
    • NGS Primary Data Analysis
    • NGS Secondary Data Analysis
    • NGS Tertiary Data Analysis
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other Users
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Technology Segment
    • 1.1.2. Product Segment
    • 1.1.3. Workflow Segment
    • 1.1.4. Application Segment
    • 1.1.5. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, and Trends

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Market Drivers Analysis
      • 3.4.1.1. Decreasing costs for genetic sequencing
      • 3.4.1.2. Development of companion diagnostics and personalized medicine
      • 3.4.1.3. Rising clinical opportunity for NGS technology
      • 3.4.1.4. Technological advancements in cloud computing
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. Lack of computational efficiency for data management
      • 3.4.2.2. Non-value-based NGS reimbursement policy and regulation status
      • 3.4.2.3. Challenges associated with NGS implementation
  • 3.5. Market Analysis Tools
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.5.2. Porter's Five Forces Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Next Generation Sequencing Data Analysis Market: Technology Movement Analysis
  • 4.3. Targeted Sequencing & Resequencing
    • 4.3.1. Targeted Sequencing & Resequencing Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 4.3.2. DNA-Based Targeted Sequencing & Resequencing
      • 4.3.2.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
    • 4.3.3. RNA-Based Targeted Sequencing & Resequencing
      • 4.3.3.1. RNA -based targeted sequencing & resequencing market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.4. Whole Genome Sequencing
    • 4.4.1. Whole Genome Sequencing Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 4.5. Whole Exome Sequencing
    • 4.5.1. Whole Exome Sequencing Market Estimates and Forecast, 2021 - 2033 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Next Generation Sequencing Data Analysis Market: Product Movement Analysis
  • 5.3. Platforms
    • 5.3.1. Platforms Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 5.3.2. Sequencing
      • 5.3.2.1. Sequencing Platforms Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 5.3.3. Data Analysis
      • 5.3.3.1. Data Analysis Platforms Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 5.4. Consumables
    • 5.4.1. Consumables Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 5.4.2. Sample Preparation
      • 5.4.2.1. Sample Preparation Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 5.4.3. Target Enrichment
      • 5.4.3.1. Target Enrichment Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others Market Estimates and Forecast, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Next Generation Sequencing Data Analysis Market: Application Movement Analysis
  • 6.3. Oncology
    • 6.3.1. Oncology Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.3.2. Diagnostics & Screening
      • 6.3.2.1. Diagnostics & Screening Market Estimates And Forecast, 2021 - 2033 (USD Million)
      • 6.3.2.2. Oncology screening
        • 6.3.2.2.1. Oncology Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
        • 6.3.2.2.2. Sporadic Cancer Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
        • 6.3.2.2.3. Inherited Cancer Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
      • 6.3.2.3. Companion diagnostics
        • 6.3.2.3.1. Companion Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
      • 6.3.2.4. Other Diagnostics
        • 6.3.2.4.1. Other Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.3.3. Research Studies
      • 6.3.3.1. Research Studies Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.4. Clinical Investigation
    • 6.4.1. Clinical Investigation Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.4.2. Infectious Diseases
      • 6.4.2.1. Infectious Diseases Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.4.3. Idiopathic Diseases
      • 6.4.3.1. Idiopathic Diseases Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.4.4. Inherited Diseases
      • 6.4.4.1. Inherited Diseases Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.4.5. Non-communicable/other Diseases
      • 6.4.5.1. Reproductive Health Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.5. Reproductive Health
    • 6.5.1. Clinical Investigation Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.5.2. NIPT
      • 6.5.2.1. NIPT Market Estimates and Forecast, 2021 - 2033 (USD Million)
      • 6.5.2.2. Aneuploidy
        • 6.5.2.2.1. Aneuploidy Market Estimates and Forecast, 2021 - 2033 (USD Million)
      • 6.5.2.3. Microdeletions
        • 6.5.2.3.1. Microdeletions Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.5.3. PGT
      • 6.5.3.1. PGT Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.5.4. Newborn Genetic Screening
      • 6.5.4.1. Newborn Genetic Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 6.5.5. Single Gene Analysis Market
      • 6.5.5.1. Single Gene Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.6. HLA Typing/Immune System Monitoring
    • 6.6.1. HLA Typing/Immune System Monitoring Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.7. Metagenomics, Epidemiology & Drug Development
    • 6.7.1. Metagenomics, Epidemiology & Drug Development Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.8. Agrigenomics & Forensics
    • 6.8.1. Agrigenomics & Forensics Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 6.9. Consumer Genomics
    • 6.9.1. Consumer Genomics Market Estimates and Forecast, 2021 - 2033 (USD Million)

Chapter 7. Workflow Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Next Generation Sequencing Data Analysis Market: Workflow Movement Analysis
  • 7.3. Presequencing
    • 7.3.1. Presequencing Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.3.2. Nucleic Acid Extraction
      • 7.3.2.1. Nucleic Acid Extraction Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.3.3. Library Preparation
      • 7.3.3.1. Library Preparation Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 7.4. Sequencing
    • 7.4.1. Sequencing Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 7.5. Data Analysis
    • 7.5.1. Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.5.2. Primary Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
      • 7.5.2.1. Primary Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.5.3. Secondary Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
      • 7.5.3.1. Secondary Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.5.4. Tertiary Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)
      • 7.5.4.1. Tertiary Data Analysis Market Estimates and Forecast, 2021 - 2033 (USD Million)

Chapter 8. End - Use Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. Next Generation Sequencing Market: End - Use Movement Analysis
  • 8.3. Academic Research
    • 8.3.1. Academic Research Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 8.4. Clinical Research
    • 8.4.1. Clinical Research Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 8.5. Hospitals & Clinics
    • 8.5.1. Hospitals & Clinics Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 8.6. Pharmaceutical & Biotech Entities
    • 8.6.1. Pharmaceutical & Biotech Entities Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • 8.7. Other Users
    • 8.7.1. Other Users Market Estimates and Forecast, 2021 - 2033 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Next Generation Sequencing Market Share, By Region, 2025 & 2033
  • 9.2. North America
    • 9.2.1. North America next generation sequencing market, 2021 - 2033 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key country dynamics
      • 9.2.2.2. U.S. next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.2.2.3. Target disease prevalence
      • 9.2.2.4. Competitive scenario
      • 9.2.2.5. Regulatory framework
      • 9.2.2.6. Reimbursement scenario
    • 9.2.3. Canada
      • 9.2.3.1. Key country dynamics
      • 9.2.3.2. Canada next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.2.3.3. Target disease prevalence
      • 9.2.3.4. Competitive scenario
      • 9.2.3.5. Regulatory framework
      • 9.2.3.6. Reimbursement scenario
    • 9.2.4. Mexico
      • 9.2.4.1. Key country dynamics
      • 9.2.4.2. Mexico next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.2.4.3. Target disease prevalence
      • 9.2.4.4. Competitive scenario
      • 9.2.4.5. Regulatory framework
      • 9.2.4.6. Reimbursement scenario
  • 9.3. Europe
    • 9.3.1. Europe Next Generation Sequencing market, 2021 - 2033 (USD Million)
    • 9.3.2. Germany
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Germany next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.3.2.3. Target disease prevalence
      • 9.3.2.4. Competitive scenario
      • 9.3.2.5. Regulatory framework
      • 9.3.2.6. Reimbursement scenario
    • 9.3.3. UK
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. UK next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.3.3.3. Target disease prevalence
      • 9.3.3.4. Competitive scenario
      • 9.3.3.5. Regulatory framework
      • 9.3.3.6. Reimbursement scenario
    • 9.3.4. France
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. France next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.3.4.3. Target disease prevalence
      • 9.3.4.4. Competitive scenario
      • 9.3.4.5. Regulatory framework
      • 9.3.4.6. Reimbursement scenario
    • 9.3.5. Italy
      • 9.3.5.1. Key country dynamics
      • 9.3.5.2. Italy next generation sequencing (NGS) market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.3.5.3. Target disease prevalence
      • 9.3.5.4. Competitive scenario
      • 9.3.5.5. Regulatory framework
      • 9.3.5.6. Reimbursement scenario
    • 9.3.6. Spain
      • 9.3.6.1. Key country dynamics
      • 9.3.6.2. Spain next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.3.6.3. Target disease prevalence
      • 9.3.6.4. Competitive scenario
      • 9.3.6.5. Regulatory framework
      • 9.3.6.6. Reimbursement scenario
    • 9.3.7. Denmark
      • 9.3.7.1. Key country dynamics
      • 9.3.7.2. Denmark next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.3.7.3. Target disease prevalence
      • 9.3.7.4. Competitive scenario
      • 9.3.7.5. Regulatory framework
      • 9.3.7.6. Reimbursement scenario
    • 9.3.8. Sweden
      • 9.3.8.1. Key country dynamics
      • 9.3.8.2. Sweden next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.3.8.3. Target disease prevalence
      • 9.3.8.4. Competitive scenario
      • 9.3.8.5. Regulatory framework
      • 9.3.8.6. Reimbursement scenario
    • 9.3.9. Norway
      • 9.3.9.1. Key country dynamics
      • 9.3.9.2. Norway next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.3.9.3. Target disease prevalence
      • 9.3.9.4. Competitive scenario
      • 9.3.9.5. Regulatory framework
      • 9.3.9.6. Reimbursement scenario
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific next generation sequencing market, 2021 - 2033 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Japan next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.4.2.3. Target disease prevalence
      • 9.4.2.4. Competitive scenario
      • 9.4.2.5. Regulatory framework
      • 9.4.2.6. Reimbursement scenario
    • 9.4.3. China
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. China next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.4.3.3. Target disease prevalence
      • 9.4.3.4. Competitive scenario
      • 9.4.3.5. Regulatory framework
      • 9.4.3.6. Reimbursement scenario
    • 9.4.4. India
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. India next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.4.4.3. Target disease prevalence
      • 9.4.4.4. Competitive scenario
      • 9.4.4.5. Regulatory framework
      • 9.4.4.6. Reimbursement scenario
    • 9.4.5. South Korea
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. South Korea next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.4.5.3. Target disease prevalence
      • 9.4.5.4. Competitive scenario
      • 9.4.5.5. Regulatory framework
      • 9.4.5.6. Reimbursement scenario
    • 9.4.6. Australia
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Australia next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.4.6.3. Target disease prevalence
      • 9.4.6.4. Competitive scenario
      • 9.4.6.5. Regulatory framework
      • 9.4.6.6. Reimbursement scenario
    • 9.4.7. Thailand
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Thailand next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.4.7.3. Target disease prevalence
      • 9.4.7.4. Competitive scenario
      • 9.4.7.5. Regulatory framework
      • 9.4.7.6. Reimbursement scenario
  • 9.5. Latin America
    • 9.5.1. Latin America next generation sequencing market, 2021 - 2033 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Brazil next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.5.2.3. Target disease prevalence
      • 9.5.2.4. Competitive scenario
      • 9.5.2.5. Regulatory framework
      • 9.5.2.6. Reimbursement scenario
    • 9.5.3. Argentina
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Argentina next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.5.3.3. Target disease prevalence
      • 9.5.3.4. Competitive scenario
      • 9.5.3.5. Regulatory framework
      • 9.5.3.6. Reimbursement scenario
  • 9.6. MEA
    • 9.6.1. MEA next generation sequencing market, 2021 - 2033 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. South Africa next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.6.2.3. Target disease prevalence
      • 9.6.2.4. Competitive scenario
      • 9.6.2.5. Regulatory framework
      • 9.6.2.6. Reimbursement scenario
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Saudi Arabia next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.6.3.3. Target disease prevalence
      • 9.6.3.4. Competitive scenario
      • 9.6.3.5. Regulatory framework
      • 9.6.3.6. Reimbursement scenario
    • 9.6.4. UAE
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. UAE next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.6.4.3. Target disease prevalence
      • 9.6.4.4. Competitive scenario
      • 9.6.4.5. Regulatory framework
      • 9.6.4.6. Reimbursement scenario
    • 9.6.5. Kuwait
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Kuwait next generation sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 9.6.5.3. Target disease prevalence
      • 9.6.5.4. Competitive scenario
      • 9.6.5.5. Regulatory framework
      • 9.6.5.6. Reimbursement scenario

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2025
  • 10.4. Company Profiles/Listing
    • 10.4.1. Illumina
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. F. Hoffman-La Roche Ltd.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. QIAGEN
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Thermo Fisher Scientific, Inc.
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Bio-Rad Laboratories, Inc.
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Oxford Nanopore Technologies
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Revvity, Inc.
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. PacBio
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Merk KGaA
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. BGI
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 4 North America Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 North America Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 North America Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 7 North America Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 U.S. Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 9 U.S. Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 U.S. Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 11 U.S. Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 12 U.S. Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 Canada Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 14 Canada Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 15 Canada Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 Canada Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 17 Canada Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 18 Mexico Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 19 Mexico Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 20 Mexico Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 21 Mexico Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 22 Mexico Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 Europe Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 24 Europe Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 25 Europe Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 26 Europe Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 27 Europe Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 28 Germany Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 29 Germany Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 30 Germany Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 31 Germany Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 32 Germany Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 33 UK Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 34 UK Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 UK Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 36 UK Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 37 UK Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 39 France Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 40 France Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 France Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 42 France Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 43 Italy Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 44 Italy Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 45 Italy Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 46 Italy Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 47 Italy Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 48 Spain Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 49 Spain Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 50 Spain Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 51 Spain Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 52 Spain Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 53 Denmark Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 54 Denmark Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 Denmark Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 56 Denmark Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 57 Denmark Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Sweden Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 59 Sweden Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 60 Sweden Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 61 Sweden Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 62 Sweden Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 63 Norway Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 64 Norway Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 65 Norway Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Norway Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 67 Norway Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 68 Asia Pacific Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 69 Asia Pacific Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 70 Asia Pacific Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 71 Asia Pacific Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 72 Asia Pacific Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 73 Japan Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 74 Japan Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 75 Japan Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 76 Japan Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 77 Japan Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 78 China Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 79 China Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 80 China Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 81 China Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 82 China Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 India Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 84 India Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 85 India Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 India Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 87 India Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 88 South Korea Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 89 South Korea Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 90 South Korea Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 91 South Korea Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 92 South Korea Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 93 Australia Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 94 Australia Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 95 Australia Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 96 Australia Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 97 Australia Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 98 Thailand Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 99 Thailand Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 100 Thailand Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 101 Thailand Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 102 Thailand Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 103 Latin America Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 104 Latin America Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 105 Latin America Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 106 Latin America Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 107 Latin America Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 108 Brazil Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 109 Brazil Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 110 Brazil Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 111 Brazil Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 112 Brazil Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Argentina Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 114 Argentina Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 115 Argentina Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 116 Argentina Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 117 Argentina Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 118 Middle East & Africa Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 119 Middle East & Africa Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 120 Middle East & Africa Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 121 Middle East & Africa Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 122 Middle East & Africa Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 123 South Africa Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 124 South Africa Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 125 South Africa Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 126 South Africa Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 127 South Africa Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 128 Saudi Arabia Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 129 Saudi Arabia Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 130 Saudi Arabia Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 131 Saudi Arabia Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 132 Saudi Arabia Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 133 UAE Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 134 UAE Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 135 UAE Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 136 UAE Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 137 UAE Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 138 Kuwait Next Generation Sequencing Market, By Technology, 2021 - 2033 (USD Million)
  • Table 139 Kuwait Next Generation Sequencing Market, By Product, 2021 - 2033 (USD Million)
  • Table 140 Kuwait Next Generation Sequencing Market, By Application, 2021 - 2033 (USD Million)
  • Table 141 Kuwait Next Generation Sequencing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 142 Kuwait Next Generation Sequencing Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Next Generation Sequencing, Market Segmentation
  • Fig. 8 Market Snapshot, 2025
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Global Next Generation Sequencing Market: Product Movement Analysis
  • Fig. 15 Global Next Generation Sequencing Market, for Platforms, 2021 - 2033 (USD Million)
  • Fig. 16 Global Next Generation Sequencing Market, for Sequencing, 2021 - 2033 (USD Million)
  • Fig. 17 Global Next Generation Sequencing Market, for Data Analysis, 2021 - 2033 (USD Million)
  • Fig. 18 Global Next Generation Sequencing Market, for Consumables, 2021 - 2033 (USD Million)
  • Fig. 19 Global Next Generation Sequencing Market, for Sample Preparation, 2021 - 2033 (USD Million)
  • Fig. 20 Global Next Generation Sequencing Market, for Target Enrichment, 2021 - 2033 (USD Million)
  • Fig. 21 Global Next Generation Sequencing Market: Application, Movement Analysis
  • Fig. 22 Global Next Generation Sequencing Market, for Oncology, 2021 - 2033 (USD Million)
  • Fig. 23 Global Next Generation Sequencing Market, for Diagnostics & Screening, 2021 - 2033 (USD Million)
  • Fig. 24 Global Next Generation Sequencing Market, for Screening, 2021 - 2033 (USD Million)
  • Fig. 25 Global Next Generation Sequencing Market, for Sporadic Cancer, 2021 - 2033 (USD Million)
  • Fig. 26 Global Next Generation Sequencing Market, for Inherited Cancer, 2021 - 2033 (USD Million)
  • Fig. 27 Global Next Generation Sequencing Market, for Companion Diagnostics, 2021 - 2033 (USD Million)
  • Fig. 28 Global Next Generation Sequencing Market, for Other Diagnostics, 2021 - 2033 (USD Million)
  • Fig. 29 Global Next Generation Sequencing Market, for Research Studies, 2021 - 2033 (USD Million)
  • Fig. 30 Global Next Generation Sequencing Market, for Clinical Investigation, 2021 - 2033 (USD Million)
  • Fig. 31 Global Next Generation Sequencing Market for Infectious Diseases 2021 - 2033 (USD Million)
  • Fig. 32 Global Next Generation Sequencing Market, for Idiopathic Diseases, 2021 - 2033 (USD Million)
  • Fig. 33 Global Next Generation Sequencing Market, for Inherited Diseases, 2021 - 2033 (USD Million)
  • Fig. 34 Global Next Generation Sequencing Market, for Non-Communicable/Other Diseases, 2021 - 2033 (USD Million)
  • Fig. 35 Global Next Generation Sequencing Market, for Reproductive Health, 2021 - 2033 (USD Million)
  • Fig. 36 Global Next Generation Sequencing Market, for NIPT, 2021 - 2033 (USD Million)
  • Fig. 37 Global Next Generation Sequencing Market for Aneuploidy, 2021 - 2033 (USD Million)
  • Fig. 38 Global Next Generation Sequencing Market, for Microdeletions, 2021 - 2033 (USD Million)
  • Fig. 39 Global Next Generation Sequencing Market, for PGT, 2021 - 2033 (USD Million)
  • Fig. 40 Global Next Generation Sequencing Market for Newborn Genetic Screening, 2021 - 2033 (USD Million)
  • Fig. 41 Global Next Generation Sequencing Market, for Single Gene Analysis, 2021 - 2033 (USD Million)
  • Fig. 42 Global Next Generation Sequencing Market, for HLA Typing/Immune System Monitoring, 2021 - 2033 (USD Million)
  • Fig. 43 Global Next Generation Sequencing Market, for Metagenomics, Epidemiology & Drug Development, 2021 - 2033 (USD Million)
  • Fig. 44 Global Next Generation Sequencing Market for Agrigenomics & Forensics, 2021 - 2033 (USD Million)
  • Fig. 45 Global Next Generation Sequencing Market, for Consumer Genomics, 2021 - 2033 (USD Million)
  • Fig. 46 Global Next Generation Sequencing Market: Technology Movement Analysis
  • Fig. 47 Global Next Generation Sequencing Market for Whole Genome Sequencing, 2021 - 2033 (USD Million)
  • Fig. 48 Global Next Generation Sequencing Market, for Whole Exome Sequencing, 2021 - 2033 (USD Million)
  • Fig. 49 Global Next Generation Sequencing Market, for Targeted Sequencing & Resequencing, 2021 - 2033 (USD Million)
  • Fig. 50 Global Next Generation Sequencing Market, for DNA-based, 2021 - 2033 (USD Million)
  • Fig. 51 Global Next Generation Sequencing Market for RNA-based, 2021 - 2033 (USD Million)
  • Fig. 52 Global Next Generation Sequencing Market: Workflow Movement Analysis
  • Fig. 53 Global Next Generation Sequencing Market, for Pre-Sequencing, 2021 - 2033 (USD Million)
  • Fig. 54 Global Next Generation Sequencing Market, for Nucleic Acid Extraction, 2021 - 2033 (USD Million)
  • Fig. 55 Global Next Generation Sequencing Market for Library Prepartion, 2021 - 2033 (USD Million)
  • Fig. 56 Global Next Generation Sequencing Market for Sequencing, 2021 - 2033 (USD Million)
  • Fig. 57 Global Next Generation Sequencing Market for NGS Data Analysis, 2021 - 2033 (USD Million)
  • Fig. 58 Global Next Generation Sequencing Market for NGS Primary Data Analysis, 2021 - 2033 (USD Million)
  • Fig. 59 Global Next Generation Sequencing Market for NGS Secondary Data Analysis, 2021 - 2033 (USD Million)
  • Fig. 60 Global Next Generation Sequencing Market for NGS Tertiary Data Analysis, 2021 - 2033 (USD Million)
  • Fig. 61 Global Next Generation Sequencing Market: End Use Movement Analysis
  • Fig. 62 Global Next Generation Sequencing Market for Academic Research, 2021 - 2033 (USD Million)
  • Fig. 63 Global Next Generation Sequencing Market for Clinical Research, 2021 - 2033 (USD Million)
  • Fig. 64 Global Next Generation Sequencing Market for Hospitals & Clinics, 2021 - 2033 (USD Million)
  • Fig. 65 Global Next Generation Sequencing Market for Pharma & Biotech Entities, 2021 - 2033 (USD Million)
  • Fig. 66 Global Next Generation Sequencing Market for Other users, 2021 - 2033 (USD Million)
  • Fig. 67 Regional Marketplace: Key Takeaways Other users
  • Fig. 68 Regional Outlook, 2022 & 2033
  • Fig. 69 Global Next Generation Sequencing Market: Region Movement Analysis
  • Fig. 70 North America Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 71 U.S. Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 72 Canada Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 73 Mexico Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 74 Europe Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 75 Germany Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 76 UK Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 77 France Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 78 Italy Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 79 Spain Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 80 Denmark Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 81 Sweden Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 82 Norway Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 83 Asia Pacific Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 84 Japan Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 85 China Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 86 India Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 87 South Korea Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 88 Australia Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 89 Thailand Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 90 Latin America Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 91 Brazil Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 92 Argentina Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 93 Middle East and Africa Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 94 South Africa Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 95 Saudi Arabia Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 96 UAE Next Generation Sequencing Market, 2021 - 2033 (USD Million)
  • Fig. 97 Kuwait Next Generation Sequencing Market, 2021 - 2033 (USD Million)